Please login to the form below

Not currently logged in
Email:
Password:

Tredaptive authorised in the EU

New cholesterol-lowering drug, Tredaptive, has been given marketing authorisation for use in all 27-member countries of the European Union, as well as Iceland and Norway
New cholesterol-lowering drug, Tredaptive, has been given marketing authorisation for use in all 27-member countries of the European Union, as well as Iceland and Norway.

The Merck Sharp & Dhome (MSD) manufactured medicine has been developed for the treatment of patients with dyslipidaemia, which can be a side effect of diabetes, and raised cholesterol. It has been licensed for use in combination with statins or as a monotherapy when statins are inappropriate.

According to MSD, non-pharmacological, dietary remedies such as exercise and weight reduction should be continued while patients are being treated with the medicine.

Professor Ian Young, consultant in clinical biochemistry at Queen's University in Belfast called the new drug 'an important treatment option'.

"The approval of Tredaptive in the European Union further reinforces our long-standing commitment to the cardiovascular area by bringing novel and innovative therapies to patients," said Stefan Oschmann, president of MSD Europe, Middle East, Africa and Canada.

22nd July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics